Lipocine (LPCN) Total Debt (2018 - 2022)
Lipocine's (LPCN) quarterly Total Debt came in at $1.5 million in Q1 2022, down 68.96% YoY from $4.8 million in Q1 2021, and down 62.74% on a QoQ basis from $4.0 million in Q4 2021.
Lipocine (LPCN) Total Debt (2018 - 2022) Analysis & Trends
Lipocine (LPCN) has 5 years of Total Debt data on file, last reported at $1.5 million in Q1 2022.
- Quarterly Total Debt fell 68.96% year-over-year to $1.5 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $1.5 million (down 68.96% YoY) and the FY2021 annual result came in at $4.0 million, down 28.85% from the prior year.
- Total Debt declined to $1.5 million in Q1 2022, from $4.0 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $12.5 million in Q1 2019 to a low of $1.5 million in Q1 2022.
- A 5-year average of $7.4 million and a median of $6.4 million in 2020 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2019 — Total Debt advanced 10.23% — and 2022, when it slumped 68.96%.
- Tracing LPCN's Total Debt over 5 years: stood at $10.3 million in 2018, then plunged by 30.33% to $7.1 million in 2019, then retreated by 21.79% to $5.6 million in 2020, then dropped by 28.85% to $4.0 million in 2021, then sank by 62.74% to $1.5 million in 2022.
- The last three Total Debt figures came in at $1.5 million (Q1 2022), $4.0 million (Q4 2021), and $5.6 million (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Lipocine | 11.34 Mn | -12.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 3.98 Mn |
| Sep 30, 2021 | 5.64 Mn |
| Jun 30, 2021 | 3.96 Mn |
| Mar 31, 2021 | 4.78 Mn |
| Dec 31, 2020 | 5.59 Mn |
| Sep 30, 2020 | 6.36 Mn |
| Jun 30, 2020 | 6.33 Mn |
| Mar 31, 2020 | 6.35 Mn |
| Dec 31, 2019 | 7.15 Mn |
| Sep 30, 2019 | 7.94 Mn |
| Jun 30, 2019 | 8.72 Mn |
| Mar 31, 2019 | 12.50 Mn |
| Dec 31, 2018 | 10.26 Mn |
| Sep 30, 2018 | 12.34 Mn |
| Jun 30, 2018 | 11.55 Mn |
| Mar 31, 2018 | 11.34 Mn |